You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
|
|---|---|
| Published in |
Trials, August 2013
|
| DOI | 10.1186/1745-6215-14-261 |
| Pubmed ID | |
| Authors |
Daniel Hofmann, Ulrike Nitz, Oleg Gluz, Ronald E Kates, Timo Schinkoethe, Peter Staib, Nadia Harbeck |
Mendeley readers
The data shown below were compiled from readership statistics for 149 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | <1% |
| Unknown | 148 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 13% |
| Other | 19 | 13% |
| Student > Master | 17 | 11% |
| Student > Ph. D. Student | 16 | 11% |
| Student > Postgraduate | 11 | 7% |
| Other | 22 | 15% |
| Unknown | 44 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 61 | 41% |
| Biochemistry, Genetics and Molecular Biology | 8 | 5% |
| Nursing and Health Professions | 6 | 4% |
| Agricultural and Biological Sciences | 5 | 3% |
| Computer Science | 3 | 2% |
| Other | 14 | 9% |
| Unknown | 52 | 35% |